Dr. Salgia is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
Medical Oncology and Therapeutics Research
1500 East Duarte Road
Duarte, CA 91010Phone+1 626-256-4673Fax+1 626-471-7322
Education & Training
- Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer InstituteFellowship, Hematology and Medical Oncology, 1990 - 1993
- Johns Hopkins UniversityResidency, Internal Medicine, 1987 - 1990
- Loyola University Chicago Stritch School of MedicineClass of 1987, MD
- Loyola University Chicago Stritch School of MedicinePhD, 1985
Certifications & Licensure
- CA State Medical License 2016 - 2025
- IL State Medical License 2003 - 2017
- MA State Medical License 1990 - 2005
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- 5 citationsA Closer Look at EGFR Inhibitor Resistance in Non-Small Cell Lung Cancer through the Lens of Precision Medicine.Martin Sattler, Isa Mambetsariev, Jeremy Fricke, Tingting Tan, Sariah Liu
Journal of Clinical Medicine. 2023-03-01 - 20 citationsPrecision oncology provides opportunities for targeting KRAS-inhibitor resistance.Martin Sattler, Atish Mohanty, Prakash Kulkarni, Ravi Salgia
Trends in Cancer. 2023-01-01 - 6 citationsPredicting survival of NSCLC patients treated with immune checkpoint inhibitors: Impact and timing of immune-related adverse events and prior tyrosine kinase inhibitor...Michael R Sayer, Isa Mambetsariev, Kun-Han Lu, Chi Wah Wong, Ashley Duche
Frontiers in Oncology. 2023-01-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: